Feasibility Evaluation of using PAX1/JAM3 methylation markers as cervical cancer screening for female self-collected samples
Objective To explore the application value of PAX1/JAM3 methylation detection by cervical self-collected specimen in cervical cancer screening and the management of premenopausal and postmenopausal women.Method This study is a single center cross-sectional study.From January 2023 to November 2023,cervical self-collected and physician-collected specimens at the colposcopy clinic were detected the PAX1/JAM3 methylation(PAX1m/JAM3m)testing.The consistency between self-collected and physician-collected specimens for PAX1m/JAM3m detection were compared based on histopathology.In addition,the clinical efficacy of methylation detection with high-risk human papillomavirus(hrHPV),liquid-based cytology(LBC),and their combination for cervical cancer screening were compared in the study.Results A total of 301 women were recruited to undergo referral colposcopy examination,and statistical analysis was conducted on 272 women with pathological and diagnostic information.Among them,102 cases(37.5％)were diagnosed as normal cervical tissue or chronic cervicitis,72 cases(26.4％)were cervical intraepithelial neoplasia grade 1(CIN1),43 cases(15.8％)were CIN2,29 cases(10.7％)were CIN3,and 26 cases(9.6％)were cervical cancer.According to the minimum quantity formula,they were divided into a consistency cohort of 81 participants and a validation cohort of 191 participants.The consistency between cervical self-collected and physician-collected specimens for detecting PAX1m/JAM3m.Results from spearman correlation analysis showed a positive correlation between the self-collected and physician-collected results of PAX1m/JAM3m detection,and the correlation coefficient R values are 0.858(P＜0.001)and 0.828(P＜0.001).The sensitivity and specificity of PAX1m/JAM3m detection for diagnosing CIN2 or more severe lesions(CIN2+)were 77.6％[95％confidence interval(CI)65.3％-86.4％]and 87.2％(95％CI 80.5％-91.9％),respectively.In clinical performance comparison,the sensitivity of PAX1m/JAM3m combined with HPV16/18 detection,89.7％(95％CI 79.2％-95.2％),was the same as that of hrHPV detection in CIN2+and 96.0％(95％CI 80.4％-99.3％)in CIN3+,which is higher than 92.0％(95％CI 75.0％-97.8％)of hrHPV and 82.6％(95％CI 62.9％-93.0％)of LBC or the combination of sPAX1m/JAM3m and LBC low-grade and higher squamous intraepithelial lesion testing[87.0％(95％CI 67.9％-95.5％)].Conclusions Self-collected specimens by women for detection of PAX1 and JAM 3 methylation as a promising screening tool for cervical cancer has operational and clinical feasibility.The methylation test can optimize the current cervical cancer screening plan,reduce the number of referral women with false positive diagnosis to colposcopy,and is of great significance for reducing fertility protection and preventing missed diagnosis in women of childbearing age.
万方数据
维普
